Construction of a genetically defined Salmonella typhi Ty2 aroA, aroC mutant for the engineering of a candidate oral typhoid-tetanus vaccine.
Chatfield, SN
Fairweather, N
Charles, I
Pickard, D
Levine, M
Hone, D
Posada, M
Strugnell, RA
Dougan, G
- Publication Type:
- Journal Article
- Citation:
- Vaccine, 1992, 10 (1), pp. 53 - 60
- Issue Date:
- 1992
Closed Access
Filename | Description | Size | |||
---|---|---|---|---|---|
2009002900OK.pdf | 1.4 MB | Adobe PDF |
Copyright Clearance Process
- Recently Added
- In Progress
- Closed Access
This item is closed access and not available.
Full metadata record
Field | Value | Language |
---|---|---|
dc.contributor.author | Chatfield, SN | en_US |
dc.contributor.author | Fairweather, N | en_US |
dc.contributor.author | Charles, I | en_US |
dc.contributor.author | Pickard, D | en_US |
dc.contributor.author | Levine, M | en_US |
dc.contributor.author | Hone, D | en_US |
dc.contributor.author | Posada, M | en_US |
dc.contributor.author | Strugnell, RA | en_US |
dc.contributor.author | Dougan, G | en_US |
dc.date.issued | 1992 | en_US |
dc.identifier.citation | Vaccine, 1992, 10 (1), pp. 53 - 60 | en_US |
dc.identifier.issn | 0264-410X | en_US |
dc.identifier.uri | http://hdl.handle.net/10453/13400 | |
dc.description.abstract | The construction of a Salmonella typhi Ty2 strain harbouring defined deletions in both the aroA and aroC genes is described. These deletions have been fully defined at the molecular level by DNA sequencing and have been introduced in such a way that no foreign DNA remains in the S. typhi genome. This strain is attenuated in mice when given by the intraperitoneal route suspended in hog gastric mucin and is attenuated to a similar level to strains harbouring deletions in aroA or aroC alone indicating that both lesions are capable of attenuating independently. We have used this defined S. typhi aroA aroC strain to express stably a non-toxic 50 kDa fragment of tetanus toxin (fragment C) from a gene incorporated into the chromosome. This strain has the advantage of harbouring no antibiotic-resistance markers and we consider it to be a candidate bivalent oral typhoid-tetanus vaccine. | en_US |
dc.language | eng | en_US |
dc.relation.ispartof | Vaccine | en_US |
dc.relation.isbasedon | 10.1016/0264-410x(92)90420-o | en_US |
dc.subject.classification | Virology | en_US |
dc.subject.mesh | Animals | en_US |
dc.subject.mesh | Mice, Inbred BALB C | en_US |
dc.subject.mesh | Mice | en_US |
dc.subject.mesh | Escherichia coli | en_US |
dc.subject.mesh | Salmonella typhi | en_US |
dc.subject.mesh | Chromosome Deletion | en_US |
dc.subject.mesh | Peptide Fragments | en_US |
dc.subject.mesh | DNA, Bacterial | en_US |
dc.subject.mesh | DNA Transposable Elements | en_US |
dc.subject.mesh | Tetanus Toxin | en_US |
dc.subject.mesh | Typhoid-Paratyphoid Vaccines | en_US |
dc.subject.mesh | Tetanus Toxoid | en_US |
dc.subject.mesh | Administration, Oral | en_US |
dc.subject.mesh | Chromosome Mapping | en_US |
dc.subject.mesh | Cloning, Molecular | en_US |
dc.subject.mesh | Gene Expression | en_US |
dc.subject.mesh | Amino Acid Sequence | en_US |
dc.subject.mesh | Mutation | en_US |
dc.subject.mesh | Molecular Sequence Data | en_US |
dc.title | Construction of a genetically defined Salmonella typhi Ty2 aroA, aroC mutant for the engineering of a candidate oral typhoid-tetanus vaccine. | en_US |
dc.type | Journal Article | |
utslib.citation.volume | 1 | en_US |
utslib.citation.volume | 10 | en_US |
utslib.location.activity | Netherlands | en_US |
utslib.for | 0601 Biochemistry and Cell Biology | en_US |
utslib.for | 06 Biological Sciences | en_US |
utslib.for | 07 Agricultural and Veterinary Sciences | en_US |
utslib.for | 11 Medical and Health Sciences | en_US |
dc.location.activity | ISI:A1992HL74200011 | en_US |
pubs.embargo.period | Not known | en_US |
pubs.organisational-group | /University of Technology Sydney | |
pubs.organisational-group | /University of Technology Sydney/Faculty of Science | |
pubs.organisational-group | /University of Technology Sydney/Strength - ithree - Institute of Infection, Immunity and Innovation | |
utslib.copyright.status | closed_access | |
pubs.issue | 1 | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 10 | en_US |
Abstract:
The construction of a Salmonella typhi Ty2 strain harbouring defined deletions in both the aroA and aroC genes is described. These deletions have been fully defined at the molecular level by DNA sequencing and have been introduced in such a way that no foreign DNA remains in the S. typhi genome. This strain is attenuated in mice when given by the intraperitoneal route suspended in hog gastric mucin and is attenuated to a similar level to strains harbouring deletions in aroA or aroC alone indicating that both lesions are capable of attenuating independently. We have used this defined S. typhi aroA aroC strain to express stably a non-toxic 50 kDa fragment of tetanus toxin (fragment C) from a gene incorporated into the chromosome. This strain has the advantage of harbouring no antibiotic-resistance markers and we consider it to be a candidate bivalent oral typhoid-tetanus vaccine.
Please use this identifier to cite or link to this item:
Download statistics for the last 12 months
Not enough data to produce graph